These rankings are based on data from March 2026
Company
JURA Bio
Years in business
- 9
Number of employees
- 1-10 employees
Country
- United States
JURA Bio, Inc. introduces variational synthesis, a generative AI approach to protein sequence design, reducing design costs massively. The platform generates high-quality, cost-effective biologic sequences through innovative model architecture.
API Availability
- No
Pricing
unknown
Use
Position of JURA Bio on sub rankings
March 2026
AI protein design - Overall
8 out of 17
United States - Overall
4,229 out of 17,203
AI protein design - Overall
8 out of 17
United States - Overall
4,229 out of 17,203
Industries
health & sports
research & development
Company
JURA Bio
Years in business
- 9
Number of employees
- 1-10 employees
Country
- United States
Insights
Sune Selsbæk-Reitz on promptism, fluent machines, and why AI makes it easier to stop thinking too soon
An interview with Sune Selsbæk-Reitz on his new book Promptism and why the real risk of AI is not in the technology itself, but in how we use it. He explains how fluent systems influence thinking, why knowledge matters more than ever, and what professionals should do to stay in control.
AI in E-commerce: From Practical Use Cases to Strategic Questions
An analysis of how AI is currently applied in e-commerce, based on insights from the Balkan Ecommerce Summit 2026. The article combines practical use cases with a critical perspective on strategy, measurement, and emerging developments such as agentic AI.